1-[1-(Dodecyloxy)-2-methylpropyl]-1H-1,2,3-benzotriazole, 85.0%, 100mg

Ethyl 5-bromo-6-oxo-1,6-dihydropyridazine-3-carboxylate, 98%, 250mg

1-(Benzyloxy)-2,3-difluoro-4-nitrobenzene, 97%, 500mg

Racks für Inkubationsröhrchen, PP, 72 Stellplätze, Ø 10-13 mm, 1 Stück

Tert-butyl(2s,5s)-5-(hydroxymethyl)-2-methyl-piperidine-1-carboxylate, 98%, 500mg

1,3-Dibromo-4-fluorobenzene, 70.0%, 5g

9,9-Dimethylfluorene-2-carboxylic Acid>98.0%(GC)(T)1g

4-Chloro-5-iodo-2-(methylthio)pyrimidine, 95%, 500mg

Bis-propargyl-PEG6, 1g

2-Aminocyclohexan-1-ol hydrochloride, 95+%, 5g

C-[1-(4-Fluoro-benzenesulfonyl)-piperidin-3-yl]-methylamine hydrochloride, 95.0%, 250mg

(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(pyridin-4-yl)butanoic acid, 95+%, 500mg

Lithiumsulfat, min. 99 %, wasserfrei, 250 g, kunststoffverpackung.